-
公开(公告)号:US20230080761A1
公开(公告)日:2023-03-16
申请号:US17946849
申请日:2022-09-16
发明人: William Taylor , Daniel Sipple , James Segermark
IPC分类号: A61K9/00 , A61K47/36 , A61K9/06 , A61K31/327 , A61K31/738 , C12N9/08
摘要: A hydrogel-based biological delivery vehicle used to effectively deliver drug and biological material to tissue or organ sites. More specifically, a hydrogel binding matrix having a biopolymer backbone containing carboxyl groups. Tyramine may be substituted for at least a portion of the carboxyl groups, so that, when hydrogen peroxide is added, it causes creation of covalent bonds between tyramine molecules and cross-links the hydrogel binding matrix, thereby enabling the hydrogel binding matrix to transition from liquid to gel state. The hydrogel binding matrix, in its liquid form, is capable of encapsulating drug reservoirs to create a homogenous liquid with evenly distributed particles containing drugs or target molecules. As the hydrogel binding matrix solidifies into a gel state, the newly created cross-links do not disrupt or react with the drugs or target molecules contained within the drug reservoirs. This hydrogel-based biological delivery vehicle can be used in several medical applications.
-
公开(公告)号:US20230072543A1
公开(公告)日:2023-03-09
申请号:US18056109
申请日:2022-11-16
申请人: QMARK MEDICAL INC.
发明人: Patrick H. RUANE , Sameer SHARMA
摘要: An injectable medical composition includes an acrylate and a solvent. The composition has a first viscosity at temperatures below body temperature and a second viscosity at body temperature. The first viscosity is lower than the second viscosity.
-
公开(公告)号:US11471402B2
公开(公告)日:2022-10-18
申请号:US16300660
申请日:2017-05-12
发明人: William Taylor , Daniel Sipple , James Segermark
IPC分类号: A61K9/00 , A61K47/36 , A61K9/06 , A61K31/327 , A61K31/738 , C12N9/08
摘要: A hydrogel-based biological delivery vehicle used to effectively deliver drug and biological material to tissue or organ sites. More specifically, a hydrogel binding matrix having a biopolymer backbone containing carboxyl groups. Tyramine may be substituted for at least a portion of the carboxyl groups, so that, when hydrogen peroxide is added, it causes creation of covalent bonds between tyramine molecules and cross-links the hydrogel binding matrix, thereby enabling the hydrogel binding matrix to transition from liquid to gel state. The hydrogel binding matrix, in its liquid form, is capable of encapsulating drug reservoirs to create a homogenous liquid with evenly distributed particles containing drugs or target molecules. As the hydrogel binding matrix solidifies into a gel state, the newly created cross-links do not disrupt or react with the drugs or target molecules contained within the drug reservoirs. This hydrogel-based biological delivery vehicle can be used in several medical applications.
-
公开(公告)号:US20220073652A1
公开(公告)日:2022-03-10
申请号:US17480707
申请日:2021-09-21
申请人: Gelesis LLC
发明人: Alessandro Sannino , Christian Demitri , Yishai Zohar , Eyal S. Ron , Barry J. Hand , Cosimo Saponaro
IPC分类号: C08B15/00 , A61K31/738 , A61K9/00 , A61K9/48
摘要: The present invention provides crosslinked carboxymethylcellulose having high elastic modulus coupled with high absorbance capacity when swollen in simulated gastric fluid/water (1:8) and simulated intestinal fluids. The invention further provides methods of making the crosslinked carboxymethylcellulose, compositions comprising the crosslinked carboxymethylcellulose and methods of using the crosslinked carboxymethylcellulose, for example, for treating overweight or obesity or for enhancing glycemic control.
-
公开(公告)号:US20220073651A1
公开(公告)日:2022-03-10
申请号:US17480571
申请日:2021-09-21
申请人: Gelesis LLC
IPC分类号: C08B3/12 , C08B11/12 , C08B11/08 , C08B11/20 , C08L1/08 , C08L1/28 , C08B15/00 , C08J3/075 , A61P3/04 , A23L33/24 , A61K31/738
摘要: The present invention provides a method of producing a polymer hydrogel comprising the steps of: (1) preparing an aqueous solution of a water soluble polysaccharide derivative and a polycarboxylic acid; (2) optionally agitating the solution, for example, by stirring; (3) isolating a polysaccharide derivative/polycarboxylic acid composite from the solution; and (4) heating the polysaccharide derivative/polycarboxylic acid composite at a temperature of at least about 80° C., thereby cross-linking the polysaccharide with the polycarboxylic acid. The invention also provides polymer hydrogels produced by the methods of the invention.
-
6.
公开(公告)号:US20220062326A1
公开(公告)日:2022-03-03
申请号:US17432601
申请日:2020-02-20
申请人: INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCH MÉDICALE) , UNIVERSITÉ DE LILLE , INSTITUT PASTEUR DE LILLE , CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE , UNIVERSITÉ PARIS-SACLAY
IPC分类号: A61K31/738 , A61K31/5383 , A61K31/4709 , A61K31/4375 , A61K31/496 , A61K31/7036 , A61P31/06
摘要: Multi-drug resistant tuberculosis (TB) is a major public health problem concerning about half a million cases each year. Patients hardly adhere to the current strict treatment consisting of more than 10,000 tablets over a 2-year period. There is a clear need for efficient and better-formulated medications. The inventors have previously shown that nanoparticles made of cross-linked poly-#-cyclodextrins (pβCD) are efficient vehicles for pulmonary delivery of powerful combinations of anti-TB drugs. Here, they report that in addition to be efficient drug carriers, pβCD nanoparticles are endowed with intrinsic antibacterial properties. Indeed, empty pβCD are able to impair M. tuberculosis (Mtb) establishment after pulmonary administration in mice. pβCD hamper colonisation of macrophages by Mtb by interfering with lipid rafts, without inducing toxicity. Moreover, pβCD provoke macrophage apoptosis leading to depletion of infected cells, thus creating a lung micro-environment detrimental to Mtb persistence. Taken together, the results suggest that materials made of cross-linked β-cyclodextrins (e.g. nanoparticles) loaded or not with antibiotics play an antibacterial action by its own and could be used as carrier in drug regimen formulations effective against TB.20
-
公开(公告)号:US11246937B2
公开(公告)日:2022-02-15
申请号:US16358948
申请日:2019-03-20
发明人: Sarah Mayes , Christine Schmidt
IPC分类号: A61K31/738 , A61K47/36
摘要: The application of a highly controlled, micron-sized, branched, porous architecture to enhance the handling properties and degradation rate of hydrogels is described in the instant invention. A previously described pattern created through one-step nucleated crystallization in a hydrogel film creates tunable mechanical properties and/or chemical stability for use in tissue engineering applications. The bulk mechanical properties and the degradation rate of the material can be tuned easily by the addition or subtraction of crystalline structure or by the addition and subtraction of backfill material, making this useful for a variety of applications. Relevant mechanical properties that can be tuned through the application of this unique porosity are moduli, elasticity, tensile strength, and compression strength. The method of the present invention can be applied to biopolymers and natural materials as well as synthetic materials.
-
公开(公告)号:US20200030368A1
公开(公告)日:2020-01-30
申请号:US16321674
申请日:2017-07-28
发明人: Jayanta HALDAR , Jiaul HOQUE
摘要: The present disclosure relates to a polymer network comprising a compound of Formula I cross-linked to a compound selected from the group consisting of a compound of Formula II; hyaluronate aldehyde, alginate aldehyde, dextran aldehyde, starch aldehyde, and chitosan aldehyde. It also relates to a process of preparing the polymer network. The present disclosure further relates to compositions comprising the polymer network and methods of preventing conditions and diseases that are caused by micro-organism. The present disclosure still further relates to a biocompatible antimicrobial hydrogel, a process for preparing the hydrogel, and methods of using the same, including a variety of tissue-related applications in which rapid adhesion to the tissue and gel formation is desired, as well as local delivery of pharmaceutical drugs to a site of application.
-
公开(公告)号:US10300168B2
公开(公告)日:2019-05-28
申请号:US15129876
申请日:2015-03-31
发明人: Alexander Linko , Andreas Krause , Franck Villain
IPC分类号: A61L27/20 , A61L27/26 , A61L27/50 , A61L27/52 , A61K31/737 , A61K31/738 , A61P17/00
摘要: The present invention relates to polysaccharide soft tissue fillers comprising heparosan and processes for their preparation. The polysaccharide soft tissue fillers of the present invention are advantageously used in therapeutic or cosmetic applications such as for the filling of wrinkles.
-
公开(公告)号:US10098907B2
公开(公告)日:2018-10-16
申请号:US15494915
申请日:2017-04-24
申请人: Gelesis, LLC
发明人: Alessandro Sannino , Christian Demitri , Yishai Zohar , Eyal S. Ron , Barry J. Hand , Cosimo Saponaro
IPC分类号: A61K31/738 , A61K9/16 , A61K9/48 , A61K9/00 , A61K9/14
摘要: The present invention provides a method of treating constipation and compositions useful in said method. The method comprises administering to a subject in need thereof an effective amount of a crosslinked carboxymethylcellulose having high elastic modulus coupled with high absorbance capacity when swollen in simulated gastric fluid/water (1:8) and simulated intestinal fluids.
-
-
-
-
-
-
-
-
-